Posttranslational modifications induce autoantibodies with risk prediction capability in patients with small cell lung cancer

Kristin J. Lastwika(Fred Hutch Cancer Center), Paul D. Lampe(University of Washington)
Science Translational Medicine
January 11, 2023
Cited by 13


Related Papers